EllaOne manufacturer HRA Pharma SA has come out in support of a possible pharmacy-only-to-general-sales-list (P-to-GSL) switch of emergency contraceptives in the UK, in response to a recent call by the British Pregnancy Advisory Service (BPAS) to scrap mandatory consultations for the medicine.
“Recent research amongst UK women by HRA Pharma confirms the BPAS research findings and highlights there is still a huge opportunity to bring more women into the Emergency Hormonal Contraception (EHC) category,” Kate Evans,
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?